Abstract-Diltiazem, a new 1,5-benzothiazepine derivative, antagonized calcium ion and thus caused a reduction in the contractile force of isolated papillary muscle. The antagonistic ratio of diltiazem to calcium ion was estimated to be approx. 1 : 100. A lower concentration of diltiazem (2.2 yX 10-13 M) decreased the contractile force without affecting significantly the intracellularly recorded resting and action potentials. When the concentration of the compound was increased to 2.2 x 10-5 M, only the maximum rate of rise of the action potential was reduced, while the other parameters of the ac tion potential were also affected at 1
Diltiazem, cl-3-acetoxy-cis-2,3-dihydro-5-[2-(dimethylamino)ethyl]-2-(p-methoxyphenyl) 1,5-benzothiazepin-4(5H)-one hydrochloride (1) , has been shown to be a potent coronary vasodilator (2) . It produced a significant increase in coronary blood flow without in creasing myocardial oxygen consumption. The compound also caused a slight decrease in myocardial contractile force as well as weak hypotensive and negative chronotropic ac tions in the anesthetized dog or dog heart-lung preparation (2) . From a series of pharma cological studies, it is assumed that diltiazem has a property which acts directly on the vas cular smooth muscle (3) . On the other hand, it has been reported that coronary vasodi lators such as prenylamine, verapamil, compound D 600 and nifedipine antagonized cal cium ion which is essential for excitation-contraction coupling and thus produced negative inotropic action or relaxing effect on smooth muscle (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . These calcium-antagonists are reported to interfere with the transmembrane calcium influx during excitation of cell membrane (8, 10, 11, 15, (17) (18) (19) (20) .
The present experiments were carried out to elucidate the mechanism of possible direct action of diltiazem on the muscle by examining its inter action with calcium ion. For this purpose, effect on the transmembrane potential and on the muscle contraction was investigated in the isolated cardiac papillary or ventricular muscle of guinea pig. ET AL.
MATERIALS AND METHODS
.11easurcments of contractile force of papillary muscle
Male guinea pigs weighing about 300 g were stunned and bled. The papillary muscle isolated from the right ventricle was transferred into an organ bath containing modified
Tyrode's solution (10 nil), into which oxygen was continuously bubbled. The proximal end of the muscle was fixed to a paraffin block in the bath with a tiny pin. Tendon at the distal end was tied by a thread which was connected to a strain gauge transducer. The contractile force developed by the electrical stimulation was recorded isometrically on an ink writing oscillograph. The preparation was driven at a rate of 1.3/sec by rectangular pulse stimulation of suprathreshold current of 5 cosec duration.
The pulse was applied externally to the muscle through a pair of Ag-A.CI plate electrodes (10 5 mm).
Measurements of transmenrbrane potential of ventricular muscle fibers
A small piece of isolated right ventricular muscle was fixed to a paraffin block with tiny pins in an organ bath, which contained 10 nil of modified Tyrode's solution aerated with oxygen. 
RESULTS
Effect on the contractile force of papillary muscle (Table 1) . This means that the antagonism between diltiazem and CaC12 is ap parently competitive. As illustrated in Table 1 , each molecule of diltiazem antagonized approx. 100 calcium ions.
Effect on the transmembrane potential of ventricular muscle fibers Fig. 2 and Table 2 demonstrate the effect of diltiazem on the intracellularly recorded transmembrane potentials of the ventricular muscle fibers. At a low concentration (2.2 x 10-6 M), diltiazem caused no significant influence on the resting and action potentials, where as the contractile force of isolated papillary muscle was decreased by about 10 % (Table 1) .
When the concentration of the compound was increased to 2.2 x 10-5 M, only Vmax was (Table 1) , the overshoot and V"lax were reduced and the duration of action potential measured at either 50% repolarization or 90'/0 repolarization was shortened. There was no significant change in the resting potential. Similar but somewhat stronger membrane effect was observed at 2.2x10-1 M diltiazem, where the resting potential was slightly reduced. As shown in Fig. 2 (in records of action potential at fast sweep speed), the rate of slower rise of the action potential following the rapid up stroke was not affected by a low concentration of diltiazem (2.2 x 10-s M), while it was re duced by a high concentration (1.1 x 10-4 M).
Since the contractile force reduced by diltiazem was reversed by an increase in the extra cellular concentration of CaC12, the effect of CaCl2 cn the transmcnibrane potential was ex amined in the presence of diltiazem (Table 3) . When 2.4 mM CaC12 was added to the mus CaCl2 was added 10 min after treatment with diltiazem and records were taken 5 min after addition of CaC12. Initial concentration of CaC12 was 1.8 mM. Abbreviations are similar to those used in Table 2 . Each value is the meaner--SE of 7 experiments. Significant difference (paired t-test) between control and diltiazem-treatment, §P<0.05; between diltiazem and CaC12-treatments, *P<0.05, **P<0.01. cle exposed to 2.2 x l0_s M diltiazem the overshoot was increased. Vr"ax was reduced and the duration of the action potential was shortened. No significant change was ob served on the resting potential. Similar results were also obtained after addition of CaCl2 (6 mM) in the presence of 1.1 x 10-4 M diltiazem. Simultaneous rneasurentents of transmembrane potential and contractile force of papillary muscle Effect of CaC12: When the extracellular concentration of CaC12 was increased from 1.8 mM to 5.4 mM, the contractile force of papillary muscle was augmented, while the dura tion of action potential was shortened and the overshoot was increased (Fig. 3) . Reduc tion of CaCl2 concentration from 1.8 mM to 0.45 mM caused the opposite effect.
Effect of diltiazem: Fig. 4 represents simultaneous recordings of the transmembrane potential and the contractile force of isolated papillary muscle. CaCl.> was added 10 min after addition of diltiazem. As to the contractile mechanism of cardiac ventricular muscle, it has been suggested that calcium ion flowing into the muscle during the plateau phase of action potential, fills certain intracellular calcium stores from which subsequent depolarization somehow releases accumulated calcium and thus activates the contractile system (21) (22) (23) (24) (25) (26) . The inflowing calcium ion during depolarization may also cause a regenerative release of calcium from its intracellular store, as observed in the skeletal muscle (27) (28) (29) .
In the present experiments, it was shown that higher concentrations of diltiazem (2.2 10-s M, 1.1 x 10-4 M) reduced Vmax without affecting the resting potential, i.e., they depres sed the rapid inward sodium current (30) . Reduction of Vmax has also been shown with prenylamine (6, 8, 10) or with a high concentration of verapamil (31) . Since depolariza tion in the form of sodium spike is assumed to be responsible for the contraction of cardiac muscle, triggering the release of intracellular calcium from its binding site (26) , it may be speculated that the inhibition of Vn,ax i.e., of sodium influx, is attributable to the reduction of the contractile force. However, from the following facts, it is inferred that the decrease in Vmax induced by a certain compound may not be necessarily associated with the change in contractile force (cf. 31): 1) the inhibitory action of diltiazem on the contractile force is antagonized with calcium ion, 2) the original strength of contraction was restored by ad dition of calcium ion while Vmax reduced by diltiazem was not recovered by it, 3) procaine caused inhibition of Vmax without affecting significantly the contractile force of cardiac muscle (10) .
On the other hand, diltiazem at a high concentration (1.1 x;10-4 M) decreased the over shoot and the rate of slower rise of action potential following the rapid upstroke. It has been reported that the slow inward calcium current is involved in the positive plateau of action potential (21, 25, (32) (33) (34) (35) and that the rate of slower rise of action potential is de pressed by manganese ion (36) which is known to inhibit the slow inward calcium or cal cium-sodium current (33, 34, (36) (37) (38) (39) . Therefore, the present results suggest that the in hibition of transmembrane calcium influx into the cell during depolarization may be a cause of the negative isotropic action of diltiazem. The possibility that a certain calcium-releas ing mechanism inside the cell, including calcium-induced calcium-releasing mechanism, is depressed by diltiazem cannot be ruled out, since the decrease in contractile force was observed under a condition where the transmembrane action potential was unaffected (2.2
10-s M diltiazem).
Concerning the contractile apparatus, no inhibitory effect was observed on the super precipitation of myosin B prepared from heart and skeletal muscle (Harigaya, S., personal communication).
It is generally assumed that the transmembrane electrical activity of cardiac muscle fibers in normal Tyrode's solution is largely sodium dependent and the calcium current con tributes little to the shape of the action potential (cf. 15). Thus, under the present experi mental conditions, small changes in calcium flux are difficult to estimate exactly from the change in the shape of action potential. In this respect, experiments were also carried out under a potassium depolarized condition in which the calcium current Was disclosed (15, 40) . Our results will follow in a succeeding report. At present, it is tentatively concluded that diltiazem may exhibit its negative inotropic effect by reducing the transmembrane cal cium influx and by inhibiting a certain intracellular calcium-releasing mechanism .
